NEW YORK – SpeeDx and QuantuMDx on Thursday announced a collaboration with the Foundation for Innovative New Diagnostics (FIND) to assess the feasibility of porting SpeeDx sexually transmitted infection tests to the QuantuMDx point-of-care testing device.
FIND is funding the project with an undisclosed amount.